Piperidine derivatives represent a cornerstone in modern medicinal chemistry, forming the structural backbone of numerous therapeutically significant compounds. Among these, Ethyl N-benzyl-3-oxo-4-piperidine-carboxylate Hydrochloride (CAS: 52763-21-0) is a particularly versatile building block, frequently employed in the synthesis of receptor agonists and antagonists. For pharmaceutical companies and research institutions, understanding the application and sourcing of such intermediates is crucial for advancing drug discovery pipelines.

This intermediate is valued for its potential to contribute to the development of drugs targeting various conditions, including neurological disorders, pain management, and inflammatory diseases. When procurement managers are tasked with sourcing this compound, key considerations include its purity, the reliability of the manufacturer, and the overall cost-effectiveness. A thorough supplier evaluation will often involve reviewing technical data sheets, purity assays, and the manufacturer’s capacity for custom synthesis if specialized grades are required.

As a buyer, you should prioritize suppliers who demonstrate a strong understanding of pharmaceutical quality standards and regulatory compliance. The availability of detailed product specifications, like those for Ethyl N-benzyl-3-oxo-4-piperidine-carboxylate Hydrochloride, along with readily accessible safety information, is also a strong indicator of a reputable chemical manufacturer. Engaging with suppliers who can offer not just the product but also technical support can greatly enhance the research process, making the purchase of this critical piperidine derivative a strategic advantage for any drug development program.